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Background: The clustering of genes in a pathway and the co-location of functionally related genes is widely recognized
in prokaryotes. We used these characteristics to predict the metabolic involvement for a Transcriptional Regulator (TR) of
unknown function, identified and confirmed its biological activity.
Results: A software tool that identifies the genes encoded within a defined genomic neighborhood for the subject TR
and its homologs was developed. The output lists of genes in the genetic neighborhoods, their annotated functions, the
reactants/products, and identifies the metabolic pathway in which the encoded-proteins function. When a set of TRs of
known function was analyzed, we observed that their homologs frequently had conserved genomic neighborhoods that
co-located the metabolically related genes regulated by the subject TR. We postulate that TR effectors are metabolites in
the identified pathways; indeed the known effectors were present. We analyzed Bxe_B3018 from Burkholderia xenovorans,
a TR of unknown function and predicted that this TR was related to the glycine, threonine and serine degradation. We
tested the binding of metabolites in these pathways and for those that bound, their ability to modulate TR binding to its
specific DNA operator sequence. Using rtPCR, we confirmed that methylglyoxal was an effector of Bxe_3018.
Conclusion: These studies provide the proof of concept and validation of a systematic approach to the discovery of the
biological activity for proteins of unknown function, in this case a TR. Bxe_B3018 is a methylglyoxal responsive TR that
controls the expression of an operon composed of a putative efflux system.
Keywords: Comparative genomics, Bxe_B3018, methylglyoxal, Transcriptional regulator, Anisotropy, EMSA, FAC-MS, rtPCR,
Burkholderia xenovorans LB400, Protein function discoveryBackground
Early researchers established that functional context is
often associated with genome organization when they
observed that genes for complex traits are often clus-
tered within a genome [1,2]. By capitalizing upon gen-
omic sequence information and clustering, numerous
computational studies have expanded and provided de-
tailed analyses of the association between genomic
organization and function [3-9]. The types of genomic
associations with functions include conservation of gene* Correspondence: rm-a@lanl.gov
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occurrence of genes (phylogenetic profiles) [10]. Of these
genomic associations, gene order has been described as
the most powerful [10]. Indeed proximity-based compu-
tational methods have been used effectively to associate
gene cluster profiles with functionality [11], especially
when combined with co-occurrence from phylogenetic
analysis [11]. Such methods are effective because func-
tionally related genes tend to be physically clustered to-
gether on the genome and these arrangements tend to
be conserved due to selection pressures [1,12]. One of
the more powerful characteristics of bacterial genomic
organization is the frequent collocation of an operon
with the gene for its transcriptional regulator (TR)
[12-17].entral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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of genes of related function and the frequent collocation
of the TR with its operon to help guide our experimental
investigation of TR function. TRs allow or repress tran-
scription in response to the presence of an effector mol-
ecule that influences their association or dis-association
with their target DNA operator sequence (DOS) [18].
Bacterial transcriptional regulators often respond to
small metabolite effector molecules although the identi-
fication of effector metabolites to which a given tran-
scriptional regulator responds has been experimentally
challenging [16]. Efforts to identify these metabolite ef-
fectors have been most successful by testing metabolites
generated by the actions of enzyme (s) within a specific
operon or metabolic pathway [15-17,19]. Such efforts
have tended to ignore similar metabolites or metabolites
in related areas of metabolism, however, because of a
lack of a suitable method for screening metabolites that
can bind transcriptional regulators. These studies have
for the most part found only single metabolite effectors
[19]. Homology-based examinations of TRs often iden-
tify the TR class to which it belongs, but they provide lit-
tle or no information regarding their specific function.
In-vivo experiments that provide candidate effector me-
tabolites can suffer from limitations of solubility, uptake
or efflux of the candidate effector metabolite. Mutations
either knocking out or over expressing the TR can be le-
thal or generate a global response, making interpretation
extremely complex. Additional approaches are needed to
overcome these limitations and facilitate TR function
discovery and characterization.
In our quest to discover the biological activity of TR
with unknown function we stumbled onto the right
question: How can we systematically predict the meta-
bolic network associated with TRs? Then we developed
a new method for finding and visualizing gene clusters
that have the targeted TR as a member and co-occur in
a significant number of organisms. In addition to de-
scribing the general applicability of our method here, we
investigated a Burkholderia xenovorans TR, Bxe_B3018,
of unknown function to test the method. Bxe_B3018 is
widely conserved among the Burkholderia and Pseudo-
monas genus but absent in most other bacteria. Se-
quence homology analysis suggests that it is a memberFigure 1 Genomic neighborhood of bxe_B3018. The annotations for the
protein kinase; 3022 (bxe_B3022) for a TR with unknown function; Kbl for gl
(bxe_B3019) encodes for a putative transporter; TR-3018 (bxe_B3018) for TR
3016 (bxe_B3016) for a putative 50S ribosomal protein L21 family protein anof the TetR-family of TRs. The DOS for Bxe_B3018 and
its orthologs among the Burkholderia genus has the gen-
eral sequence of C (T/G)AGAA (T/C)GATC (G/A)
TTCT (C/A)C; this sequence is also present in its own
promoter region and the promoter regions of an un-
known function gene, bxe_B3017 in B. xenovorans [20].
We identified the metabolite effector (s) of this TR and
examined the influence of the effector (s) on the TR
binding of its DOS. Based on gene neighborhoods, we
used the functional annotation of the genes in clusters
to identify the general metabolic network represented by
these clusters to guide the construction of a metabolite
library of potential effectors of this TR. In-vitro screen-
ing of this library found three metabolites that bound
Bxe_B3018. We examined the interaction of Bxe_B3018
with its DOS and the influence of these TR-binding me-
tabolites on the formation and/or collapse of the TR/
DOS complex. Also we investigated the in-vivo effects of
these metabolites on the expression of the genes within
the operon (bxe_B3016 [EMBL: ABE32981], bxe_B3017
[EMBL: ABE32980], bxe_B3018 [EMBL: ABE32979] and
bxe_B3019 [EMBL: ABE32978]) (Figure 1).
Results
Approach to the prediction of metabolic function
associated with a TR
The goal of our prediction effort was not to find the spe-
cific operon or effector molecule associated with a given
TR but rather to identify the metabolic area associated
with the TR. This metabolic area could be comprised of
one or more metabolic pathways. We used the informa-
tion in the KEGG database [21] to analyze and compare
gene clustering and genomic organization among a
chosen number of organisms containing close homologs
of our TR of interest and that were represented in the
KEGG database to discover functional patterns con-
served within the TR’s genomic neighborhood. Our ex-
periments suggest that these neighborhoods are usually
defined as 5 to 20 genes upstream and downstream of
the TR. This method draws strength from examining all
sequenced genomes containing homologs of the desired
TR for the clustering of metabolically related genes and
their conservation in a cluster (co-occurrence). It avoids
the typical limitations of methods that require strictse genes are as follow: Stk encodes for a non-specific serine/threonine
ycine C-acetyltransferase; Tdh for L-threonine 3-dehydrogenase; 3019
with unknown function; 3017 (bxe_B3017) for a putative transporter;
d Sgat (bxe_B3001) for serine-glyoxylate transaminase.
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coding sequence lengths.
Function Discovery V1.0, a gene neighborhood analysis
tool
Function Discovery V1.0 is a Java™ based computational
tool created to automate the approach to the prediction
of metabolic function associated with a TR described
above. The Additional file 1 contains all files required to
run the Java™ application. Function Discovery V1.0 re-
quires as input the three-letter KEGG Organism code
followed by the locus tag of the desired protein, the
number of organisms containing close homologs to the
protein of interest (# of homologs), the number of genes
upstream and downstream genes from the TR will define
the size of the genomic neighborhood (# of genes) and
the desired percent of amino acid identity cutoff (aa-
IDc). Our experience has suggested that utilizing be-
tween 5 and 20 genes to define the neighborhood gives
the best results. The aa-IDc will also limit the number of
homologs, for example if 100 similar genes and an aa-
IDc of 40% were selected, there will be cases where only
a few genes will satisfy the aa-IDc of 40% and the list of
homologs will be < 100. We have found that setting the
aa-IDc < 40% can include TRs from the same protein
family that are not functional homologs; while setting
aa-IDc > 40% can filter functional homologs and limit
the cross organism correlations. Because Function Dis-
covery V1.0 performs a series of online database
searches and re-arranges the information for easier ana-
lysis, the input of a large genomic neighborhood, a large
number of homologs or a low aa-IDc, significantly
lengthens the run time. The results are shown in a re-
port that contains the gene information from the KEGG
database and several tables summarizing the results of
the search (see Additional files 2, 3, 4, 5, 6, 7, 8, 9, 10
and 11 for full examples). The first table, Homolog ID,Table 1 Summary of results obtained by Function Discovery V
TRa Pathway name Known pathway gene
betI (B1590) glycine betaine synthesis betABTI
catR (A2107) benzoate degradation catABCR
cymR (A3550) p-cumate catabolism cymAaAbAcAdBCDEFHG
cysB (A2466) sulfur metabolism cysABPTWA
glpR (A0643) glycerol metabolism glpABCDKFR
hpaR (B2027) hydroxyphenylacetate catabolism hpaGEDFHIR
kynR (A0736) oxidative tryptophan degradation kynABU
hutC (A2946) histidine degradation hutHUIFGC
rcoM (A2142) carbon monoxide oxidation coxBCMSLDEFGHIK
modEB2851) molybdate transport modABCDE
aTranscriptional regulators of interest, the locus tag of the gene is in parentheses a
bGenes missing in the cluster are identified by a dash (─). This table summarizes th
of interest.shows the number of entries in the KEGG database that
satisfy both the organisms containing close homologs to
the query TR and aa-IDc. The second set of tables,
called Neighborhood Representations, presents the gen-
omic neighborhoods for each of the genes in the Homo-
log ID table. Next, the Over-represented Enzyme
Summary table gathers information on all known func-
tion proteins in the genomic neighborhoods determined
by the Neighborhood Representation tables and ranks
them by the frequency of occurrence. This is followed
by the Over-represented Metabolite Summary table,
which recollects the metabolites identified as substrates
or products of the proteins included in the Over-
represented Enzyme Summary and ranks them by fre-
quency of occurrence. Finally, the Over-represented
Pathway Summary merges the information in the previ-
ous tables to identify KEGG metabolic pathways con-
taining the proteins and metabolites and ranks them by
the highest number of hits per pathway. The higher the
ranking of a metabolic pathway in the Over-represented
Pathway Summary, the more likely it is that the TR acts
as a regulator for part or the entire metabolic pathway.
The report file created by Function Discovery V1.0 is a
HTLM file. All the tables have hyperlinks that allow the
user to access the information in the KEGG database.
Function Discovery V1.0 validation
To validate the approach to the prediction of metabolic
function associated with a TR, we analyzed ten tran-
scriptional regulators with known functions and effec-
tors utilizing our software named Function Discovery
V1.0. In regard to these ten known TRs, our software
was able to identify the metabolic pathway or genes
regulated by each TR (Table 1, utilizing 10 genes up
and down stream, a 100 homologs and a 40% aa-IDc).
Figure 2 presents the graphic user interface (GUI) for
Function Discovery V1.0 showing the parameters used1.0 when applied to ten known-function TRs
s Genes clustered with the TRb TRE Ref
betABTI choline [21]







cox──SMLDE─G ─── carbon monoxide [30]
modABC─E molybdenum [31]
nd excludes the “bxe_” prefix.
e analysis of 10 genes upstream and 10 genes downstream of the TR
Figure 2 Graphic user interface for Function Discovery V1.0. The
TR list represents the ten TRs used for validation of this approach: bxe:
Bxe_B1590 (BetI), bxe:Bxe_A2107 (CatR), bxe:Bxe_A3550 (CymR), bxe:
Bxe_A2466 (CysB), bxe:Bxe_A0643 (GlpR), bxe:Bxe_B2027 (HpaR), bxe:
Bxe_A2946 (HutC), bxe:Bxe_A0736 (KynR), bxe:Bxe_B2851 (ModE) and
bxe:Bxe_A2142 (RcoM). The parameters used were: “# of similar genes”,
100 (nearest homologs) “# of nearby genes”, 10 (meaning 10 genes
upstream and 10 genes downstream); “aa identity cutoff”, 40%.
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[EMBL: ABE34374] [22], CatR [EMBL: ABE30799] [23],
CynR [EMBL: ABE29438] [24], CysB [EMBL: ABE3
0507] [25], GlpR [EMBL: ABE32291] [26], HpaR
[EMBL: ABE33958] [27], KynR [EMBL: ABE32198]
[28,29], HutC [EMBL: ABE30031] [30,31] and RcoM
[EMBL: ABE30826] [32], the pathways known to be
regulated by the TRs were identified in the first hit in
the Over-represented Pathway Summary (Additional
files 2, 3, 4, 5, 6, 7, 8, 9 and 10); in each case the TR ef-
fector molecules are metabolic intermediates in the
pathway they regulate. The exception was ModE which
required a closer analysis of the Function Discovery
V1.0 report (Additional file 11). ModE [EMBL:
ABE33144] [33] is involved in the regulation of the mo-
lybdate transport pump system which is encoded by the
operon modABCDE. By observing the known genes and
conservation patterns in the genomic neighborhoods
(Neighborhood Representations table), we could easily
identify most of the genes in the operon encoding for
the molybdate transport system (Table 1). However,
only one of the proteins involved in this system has
been assigned an EC number, ModC (EC: 3.6.3.29),
which was identified in the genome neighborhood with
the highest frequency (see the Over-represented En-
zyme Summary table), unfortunately none of the other
components of the transport system have been assign
EC numbers. In addition, ModC is not associated withany pathway in the KEGG database, which makes it im-
possible for the Function Discovery V1.0 software to
make a pathway prediction in the Over-represented
Pathway Summary. This problem is expected to be
greater for operons encoding for efflux and transport
systems because the genes associated with them rarely
have assigned EC numbers and when they do, they may
not be associated with any pathway in the KEGG data-
base. In these cases a more detailed analysis of the
Function Discovery V1.0 results file is necessary. Des-
pite this limitation, the Function Discovery V1.0 soft-
ware has shown a remarkable ability to gather the
information necessary to associate TRs with their meta-
bolic pathway.
Prediction of metabolic function associated with TRs: the
case of Bxe_B3018
The gene encoding for our target TR of unknown func-
tion, Bxe_B3018 is present in the genome of B. xenovor-
ans. Amino acid sequence comparisons using a BLAST
search of Bxe_B3018 with the entire set of completely
and partially sequenced microbial genomes (utilizing a
40 aa-IDc) identified the existence of 81 homologs
(Additional file 12). These homologs were found only
in Burkholderia or Pseudomonas genomes.
Utilizing Function Discovery V1.0, we performed a
careful examination of the genomic neighborhood of
Bxe_B3018 (Neighborhood Representations) and its ho-
mologs (Additional file 13). The examination revealed
that, in nearly every instance, these genes were found
in close proximity to a cluster of genes involved in the
degradation of glycine, threonine and serine; these
degradation products provide substrates for the pyru-
vate metabolism pathway. Specifically, the genes for
glycine C-acetyltransferase (EC: 2.3.1.29), L-threonine
3-dehydrogenase (EC: 1.1.1.103) and homoserine kin-
ase (EC: 2.7.1.39) are in close proximity to either
Bxe_B3018 or its homologs. The physical locations of
other genes (such as serine-glyoxylate transaminase -
EC: 2.6.1.45) involved in the degradation of glycine,
threonine and serine metabolism were less well con-
served but were present in relatively close proximity to
Bxe_B3018 and its homologs. Our Function Discovery
1.0 analysis tool identified the glycine, threonine and
serine degradation pathway as the top candidate
(Over-represented Pathway Summary) and provided
hyperlinks that allow the visualization of the identified
proteins (yellow) and metabolites (red) in a pathway
map (Figure 3).
High-throughput screening of possible effectors of
Bxe_B3018: FAC-MS experiments
The predicted association of the degradation of glycine,
threonine and serine and subsequent pyruvate metabolism
Figure 3 Condense representation of the KEGG Mapper result. This pathway representation was obtained from the first pathway hit in the
Over-represented Pathway Summary of the Bxe_B3018 metabolic involvement analysis using the software Function Discovery V1.0. The results
suggest the involvement of Bxe_B3018 in the glycine, threonine and serine. The yellow rectangles the identified genes from the Over-represented
Enzyme Summary table and the red rectangles are the identified metabolites from the Over-represented Metabolite Summary.
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date effector metabolites from these metabolic pathways
(Additional file 14). These metabolites were screened for
binding to immobilized Bxe_B3018 using frontal affinity
chromatography coupled with mass spectrometry (FAC-
MS) detection of metabolites eluting from the column
(Figure 4). This method allowed for direct identification
and ranking of metabolites based on their relative binding
strengths because the order of elution of these compounds
suggests their relative strengths of binding to the effector
binding site on GST-Bxe_B3018. The ranking obtained
from screening the library of compounds identified
aminopropan-2-ol, N,N-dimethylaminoacetone and ami-
noacetone as potential effectors for Bxe_B3018. In
addition to these compounds, the assembled library also
contained methylglyoxal, a compound not readily detect-
able by our mass spectrometry method. For this reason,
its potential interaction with Bxe_B3018 was examined
using another method as described below.
Impact of potential effector metabolites on the formation
and/or collapse of the TR/DOS complex: Anisotropy
experiments
GST-Bxe-B3018 binds its DOS to form a TR/DOS
complex in the absence of an effector molecule with a
Kd of 19.0 ± 0.9 nM as estimated by fluorescence
polarization (anisotropy) experiments. We also used
this method to examine the effects of the potential ef-
fector molecules (aminoacetone, N,N-dimethylami-
noacetone, methylglyoxal and aminopropan-2-ol) on
the affinity of GST-Bxe_B3018 to its DOS. We found that
the presence of aminoacetone, N,N-dimethylaminoacetoneand methylglyoxal caused the collapse of the TR/DOS com-
plex. The Kd values for aminoacetone, N,N-dimethylami-
noacetone and methylglyoxal were (2.1 ± 0.4) mM, (2.6 ±
0.2) mM and (2.1 ± 0.2) mM, respectively. The anisotropy
experiments were not able to detect any significant disrup-
tion of the TR/DOS complex when aminopropan-2-ol was
used as an effector molecule. Other structurally related
molecules, such as acetamide, propionamide and the most
weakly bound Glyceraldehyde 3-phosphate (from our FAC-
MS experiments) did not affect the TR/DOS complex. We
could therefore surmise that these compounds were not
acting as effectors in these experiments. Dissociation con-
stants in the presence of candidate effectors were calculated
at a saturation concentration of GST-Bxe_B3018 (250 nM)
where all DOS (1 nM) was bound. Because aminopropan-
2-ol was among the most strongly bound compounds when
assayed by FAC-MS, we wondered if it would impact the
decrease in Bxe_B3018 binding to its DOS in the presence
of aminoacetone, N,N-dimethylaminoacetone or methyl-
glyoxal. Aminopropan-2-ol did not significantly affect the
affinity of GST-Bxe_B3018 to its DOS when aminoacetone
[(2.2 ± 0.2) mM], N,N-dimethylaminoacetone [(2.4 ± 0.2)
mM] or methylglyoxal [(1.9 ± 0.5) mM] were added to the
reaction mixture without previous pre-incubation; we
therefore concluded that aminopropan-2-ol was not inter-
fering with the binding of these other compounds in our
assay.
Impact of compounds bound by TR on its DOS
association: EMSA Assays
Results from electrophoresis mobility shift assays were con-
sistent with the observations obtained from the anisotropy
Figure 4 (See legend on next page.)
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Figure 4 FAC-MS elution profile for the candidate library. FAC-MS elution profile of metabolites predicted to be effector molecules of Bxe_B3018.
Chemical structures for each metabolite or metabolite analog are found in the Additional file 14.
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(Mgx) and aminopropna-2-ol (Ap) (Figure 5). The third
compound that disrupted TR/DOS complex formation,
dimethylaminoacetone, was not examined here because
it is not a metabolite and therefore not a naturally oc-
curring effector. As shown in Figure 5, lane 1 contained
unbound DOS as a control and lane 2 contained the
DOS/TR complex control. When the potential effector
molecules ([Aa] or [Mgx]) were mixed with Bxe_B3018
and the DOS, the formation of the DOS/TR complex
was disrupted (Lanes 3–5 for Aa and 6–8 for Mgx). As
the concentration of Aa and Mgx effectors increased,
there was an increase DOS/TR disruption, leading to
an increase in unbound DOS. When aminopropan-2-ol
was used as the effector, there was no disruption of the
DOS/TR complex (Lanes 9–11).Figure 5 EMSA for Bxe_B3018 and possible effectors. EMSA
examination of aminoacetone (Aa), methylglyoxal (Mgx) and
aminopropan-2-ol (Ap) as potential disruptors of DOS/GST-Bxe_B3018
complex formation. Lane 1 contained unbound DOS (1 μM) as a
control and lane 2 contained the DOS/TR complex control (10 μM
TR and 1 μM DOS, the standard concentrations for each lane in this
experiment). 10, 15 and 20 mM were the concentrations used for
effectors. Lanes 3–5 show the simultaneous incubation of TR and
its DOS in the presence of increasing concentrations of aminoacetone,
lanes 6–8 with methylglyoxal and lanes 9–11 with aminopropan-2-ol.
The image show here is representative of a single 20-lane gel, with
empty lanes omitted at the dotted lines.Effects of potential effectors on gene expression: real-
time PCR
Real-time PCR experiments were utilized to determine
whether the in-vitro-identified effector molecules (ami-
noacetone and methylglyoxal) as well as the non-
effector (animopropan-2-ol) were capable of affecting
the expression of the genes in the operon (bxe_B3016,
bxe_B3017, bxe_B3018 and bxe_B3019). Bxe_B3018
binds its DOS in the absence of an effector molecule;
incubation of B. xenovorans with the effector molecules
should cause Bxe_B3018 to release its DOS increasing the
rate of translation of the genes encoding bxe_B3016,
bxe_B3017, bxe_B3018 and bxe_B3019. Aminoacetone
and aminopropan-2-ol showed no effect on the expression
of the regulated genes with concentrations up to 10 mM
of each effector. Addition of 10 mM of methylglyoxal and
incubation for an hour led to a 40-fold increase in the ex-
pression of the regulated genes (bxe_B3016, bxe_B3017
and bxe_B3019) and a 100-fold increase in the expression
of the TR (bxe_B3018), of as measured by real-time PCR
(rtPCR).These in-vivo results suggest that methylglyoxal
was the only effector molecule able to increase translation
of the genes in the operon.
Discussion
As early as the 1930’s, geneticists observed that genes
encoding for proteins responsible for complex traits are
often clustered within the genome [1,2,34,35]. Computa-
tional approaches have estimated that an average of 58%
of bacterial genes are found in operons [36]. Proximity-
based computational methods have been used effectively
to associate gene cluster profiles with functionality
[11,37], although this approach is confounded by inser-
tions, deletions or changes in gene order [36]. To over-
come these complications, we developed an automated
gene/genomic region analysis tool that rapidly identifies,
compares and presents conserved genomic neighbor-
hoods encoding for metabolic pathways across many or-
ganisms. Our gene neighborhood examination tool,
Function Discovery V1.0, allows us to find collocations
in genomic neighborhoods across many organisms, asso-
ciating metabolic pathways with the target TR. It does
not restrict our investigation to a single organism in
which gene clustering around the target TR might not
have existed because of rearrangements, insertions or
deletions of genetic material or other events. Recently,
we reported the characterization of three TRs of un-
known function in which we used a manual version of
our approach to predict functionality and identify
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approach, Function Discovery V1.0 has also been effect-
ive in finding conserved genes clustered near our target
genes and for ten randomly chosen TRs that have
known effectors and functions (Table 1). Of course, the
ability to gain functional insights using our method is
limited by the extent to which the genes clustered near a
target gene have been functionally annotated.
In this work, we investigated a B. xenovorans TR of
unknown function, Bxe_B3018. It is widely conserved
among the Burkholderia and Pseudomonas genus but
absent in most other bacteria. There are more than 140
TRs common among the members of the Burkholderia
genus that have not been fully functionally annotated.
Characterization of these TRs is vital to the understand-
ing of the metabolism of this genus, which is character-
ized by having members with excellent environmental
adaptability and/or high pathogenicity. Function Discov-
ery V1.0 analysis suggested that Bxe_B3018 may be in-
volved in the glycine, serine and threonine degradation
pathway. The operon regulated by Bxe_B3018 is found
upstream from several genes involved in this metabol-
ism. Our software analysis coupled with our in-vitro and
in-vivo experiments suggests that it responds to a metab-
olite from the glycine, serine and threonine metabolism
pathway, methylglyoxal. Fluorescence anisotropy experi-
ments suggest that Bxe_B3018 binds methylglyoxal with
a dissociation constant of ~2 mM. Millimolar concentra-
tions of methylglyoxal in bacterial cells have been previ-
ously reported [40,41]. The Bxe_B3018-regulated operon
includes the genes bxe_B3016, bxe_B3017, bxe_B3018
and bxe_B3019. Bxe_B3017 is a hypothetical protein
that shows some sequence similarity to sn-glycerol-3-
phosphate transporters (GlpT). GlpT is a transporter
involved in antibiotic resistance in Pseudomonas aeru-
ginosa [42]. bxe_B3016 encodes a protein of unknown
function belonging to the 50S ribosomal protein L21
family. 50S is the larger subunit of the 70S ribosome of
prokaryotes and the site of inhibition of macrolides [43]
and the pleuromutilins [44] antibiotics. bxe_B3019 is a
member of the YceI family of transport proteins, a
widely conserved protein commonly involved in anti-
microbial resistance mechanisms [45,46].
Conclusions
Based on its response to methylglyoxal, we propose the
Bxe_B3018 be given functional name MgxR. The poten-
tial relationship between the functions encoded by the
MgxR-regulated operon genes and serine, glycine and
threonine degradation may be revealed by consider-
ation of the effector methylglyoxal. It is a side product
of both glycine degradation and glycolysis and is the
major electrophile produced intracellularly by bacterial
cells [41]. Methylglyoxal is a highly reactive 1,2-dicarbonylic compound that reacts readily with amino
groups, causing structural changes in proteins and
DNA and generating free radicals in the process
[40,47]. As is to be expected for such a deleterious
compound, there are several paths known for detoxifi-
cation of methylglyoxal. The sulphydryl group of gluta-
thione can react spontaneously with methylglyoxal,
followed by the actions of the glyoxalase I and glyoxa-
lase II enzymes, thus producing D-lactate, which can be
either excreted or recycled to pyruvate by lactate de-
hydrogenase [48,49]. Alternatively, bacteria can utilize
the KefB/KefC potassium pump system to acidify the
cytoplasm and inactivate the methylglyoxal [41,48,49].
Our findings suggest that B. xenovorans may have an-
other detoxification mechanism, a methylglyoxal efflux
system encoded by the MgxR regulated operon. Further
characterization of this putative efflux system encoded by
the bxe_B3016, bxe_B3017, bxe_B3018 and bxe_B3019 op-
eron is required.
Methods
Approach to the prediction of metabolic function
associated with a TR
A flowchart diagram describing the steps used by the
Function Discovery V1.0 software to predict the meta-
bolic involvement of TR is shown in the Additional file
15. We used the KEGG Sequence Similarity DataBase
(SSDB) [50] to find a set of genes similar to our target
TR. The KEGG SSDB identified all possible pairwise
genome comparisons and recorded the gene pairs with
the Smith-Waterman similarity score of 100 or more.
We used the information of bidirectional best hits (best-
best hits) to select a set of similar genes in various spe-
cies for our target TR with a cutoff of 40% amino acid
identity. For each similar gene at a position in the
chromosome, we found a set of nearby genes upstream
and downstream from the position. From those nearby
genes, we identified a subset of genes that encoded en-
zymes. We collected the metabolic reactions for those
enzymes and recorded their metabolic pathways. For
each metabolic reaction, we identified its substrates and
products (metabolites involved). The metabolites, meta-
bolic reactions and metabolic pathways identified from
the whole set of similar genes were collected. We
counted the over-representation of those metabolites,
metabolic reactions and pathways. Over-represented
metabolic reactions are more likely to be co-regulated
and belong to the same KEGG metabolic pathway. The
identified metabolites (and analogs) were good candi-
dates for experimental validation of their activity as ef-
fector molecules of the queued TR. The software tools
to implement the above procedure are written based on
KEGG SOAP API , developed under Java™ 7.0 and tested
under Windows, Mac OS and Linux operating systems.
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www.kegg.jp/kegg/rest/keggapi.html), we re-wrote the
codes (Additional file 1). We used these tools to analyze
the metabolic involvement of the 10 known-function
TRs and the unknown-function TR Bxe_B3018. Then
we manually checked the results for Bxe_B3018, deter-
mined the metabolic pathways represented in the results
and chose a library of metabolites and analogs from this
area of metabolism as candidate TR effectors for experi-
mental testing and functional validation. A full descrip-
tion and step-by-step instructions on how to use the
Function Discovery V1.0 software can be found in the
supplemental materials.
Preparation of Bxe_B3018 affinity column
The genomic DNA of B. xenovorans was isolated from
the B. xenovorans LB400 cells by following the manufac-
turer’s specified protocol for the DNA Mini Kit. The
gene encoding for Bxe_B3018 was cloned from the Bur-
kholderia xenovorans LB400 genomic DNA into the
pGEX-KG expression vector. The Bxe_B3018 gene was
amplified by conventional PCR methods using two
primers: forward 5′-GATCCATGGATGAGAACAGC
ACACCGAACCT-3′ and reverse 5′-GATCGGATCC
CTACGCCGCGTTCTCGT-3′, containing NcoI and
BamHI sites, respectively. The resulting DNA fragment
was incorporated into the NcoI and BamHI sites of the
pGEX-T2 plasmid.
The pGEX-T2 plasmid containing the gene encoding
for Bxe_B3018 was transformed into Arctic Express
competent cells. A single colony was cultured overnight
in 25 mL of LB media containing 100 mg/L ampicillin.
Then, 4 mL were used to inoculate 6 L of the same
media. Cell cultures were grown at 37°C with a rotary
shaker until an Abs600nm of ~ 0.6 OD was reached, after
which the temperature was dropped to 16°C and protein
expression was initiated by the addition of isopropyl-
thiogalactoside to a final concentration of 1.0 mM. Then,
the culture was incubated overnight at 16°C. After incu-
bation, the bacterial cells were isolated by centrifugation
at 7000 × g for 10 min at 4°C. The cell pellet was washed
and re-suspended in 20 mM Na2PO4 buffer containing
100 mM NaCl at pH 7.2 (buffer A). Also, 5 μg/mL
DNAse and 0.1 mg/mL of the protease inhibitor (PMSF)
per gram of cells were added to buffer A. The resus-
pended cells were disrupted by sonication. The soluble
protein was separated from the cell debris by centrifuga-
tion at 12,000 × g for 15 min at 4°C, then loaded onto a
5 mL GSTrap FF column equilibrated with buffer A and
eluted with a lineal gradient of 50 mM Tris-Cl and
10 mM reduced glutathione at pH 8.1 (buffer B). Frac-
tions containing Bxe_B3018 were pooled, concentrated
and loaded onto a high load 26/60 Superdex 200 prep
grade gel filtration column (GE Health Care) and elutedwith 100 mM Na2PO4 buffer containing 150 mM NaCl
at pH 7.2 (buffer C). The purity of the protein during
the isolation procedure was monitored by SDS gel.
The GST-tagged Bxe_B3018 protein was diluted to a
concentration of 1 mg/mL and loaded onto a 1 mL
GSTrap FF affinity column. After loading the GST-
tagged Bxe_B3018 protein, the FAC-MS columns were
washed with 10 column volumes of buffer A. The prep-
aration of the FAC-MS column was concluded by ex-
changing the binding buffer for a MS-friendly buffer
such as 20 mM ammonium formate at pH 7.2 (buffer C).Screening the library of possible TR effectors
A library of metabolites and structurally related com-
pounds was assembled as described in the “Approach
to the prediction of metabolic function associated with
a TR” section and used to investigate the effector bind-
ing specificity of GST-B3018. The compounds were
acetamide, aminopropan-2-ol, aminoacetone, N,N-dimethy-
laminoacetone, propanamide, glycine, dimethylglycine,
sarcosine, creatine, betaine, L-threonine, L-allo-threonine,
L-serine, D-serine, phosphor-L-serine, 5-aminlevulinate,
2-oxobutanoate, guanidinoacetate, glycerate-3-phosphate,
glyceraldehydes-3-phosphate, 2,3-diphosphoglycerate and
phosphocholine (structures in Additional file 2). The
compounds were each present in the mixture of poten-
tial effectors at 10 μM concentrations in buffer C and
the final pH was adjusted to 7.4.
The affinity columns prepared with the tagged
Bxe_B3018 protein were coupled to an Exactive Bench-
top FT Mass Spectrometer (Thermo Fisher) and the
mixture of potential effectors was continuously infused
through the column. The effluent from the column was
mixed with methanol containing 0.1% formic acid
(makeup solution) immediately before infusion to the
MS. The total flow rate used for the FAC-MS experi-
ments was 170 μL/min into the mass spectrometer in-
cluding 85 μL/min of the ligand solution and 85 μL/min
of the makeup solution. The column was connected to
the mass spectrometer and syringe pumps (OEM PSD/3
Syringe Pump, Hamilton Company) and was allowed to
equilibrate with buffer C until the background level of
the ion [M+H]+ signal was stable. Then, the system was
switched to the analyte solution (mixture of potential
effectors) and data were acquired continuously for
30 min. After each run, the column was regenerated
with 10 column volumes of buffer C in preparation for
the next run.
Fluorescence anisotropy assays of Bxe_B3018 / DOS
interaction
The Fluorescein-labeled DNA Operator Sequence (DOS)
(5′-Fluo-CGAGGGAGAATGATCGTTCTACCCTT-3′)
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GATCATTCTCCCTCG-3′) were dissolved in distilled
water to a concentration of 100 μM. The annealing reac-
tion was performed by incubating a 20 μM solution of
the two oligonucleotides in 20 mM Tris-Cl, 100 mM
NaCl and 1 mM MgCl2 at pH 7.5 at 95°C in a heat block
for 5 min, then the block was removed from the heat
source and allowed to reach room temperature. The
progressive decline to room temperature allowed the an-
nealing to occur. The fluorescence polarization experi-
ments were performed in 20 mM Tris-Cl, 60 mM KCl,
40 mM NaCl, 0.5 mM EDTA, 1.0 mM DTT, 1.0 mM
MgCl2 and 100 μM/mL BSA at pH 7.5 (buffer D). The
200 μL reaction mixture was prepared in the following
order: first 10× Buffer D was added to the wells of a
black 96-well; then 20× Fluorescein-labeled DOS was
added to a final concentration of 1 nM; then distilled
water was added to complete the 200 μL reaction vol-
ume minus the GST-Bxe_B3018 reaction volume. Fi-
nally, the reaction was initiated by the addition of the
appropriate amount the GST-Bxe_B3018 (from 0 to
250 μM final concentration). The reactions were mixed
by pipetting and incubated for one hour at 30°C in the
dark. The Fluorescein-labeled DOS was excited with po-
larized light through an excitation filter of 485/20 nm
and the emission was measured with an emission filter
of 528/20 nm with a dichroic mirror of 510 nm. Fluores-
cence polarization was monitored with a BioTek - Syn-
ergy H4 hybrid Microplate Reader and anisotropy values
calculated automatically with the Gen5 software using
the standard G factor of 0.85.
The collected data were plotted using Sigma Plot 11.0.
The dissociation constants of GST-Bxe_B3018 for its
Fluorescein-labeled DOS in the presence of possible ef-
fectors were obtained from the fluorescence polarization
experiments by fitting the change in anisotropy values
vs. the GST-Bxe_B3018 protein concentration to a modi-
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where ΔA is the change in fluorescence anisotropy, ΔAT
is the total change in anisotropy, E is the total MetJ con-
centration at each point in the titration, Kd is the dis-
sociation constant, and H is the Hill coefficient.
Electrophoresis mobility shift assay (EMSA) of Bxe_B3018/
DOS interaction
The DOS utilized in these experiments was obtained
from the upstream promoter region of Bxe_B3018. The
double stranded DOS was obtained from the annealingof two synthetic oligonucleotides. The synthetic oligonu-
cleotides used consist of a 5′-CGAGGGAGAATGAT
CGTTCTACCCTT-3′ sequence and its reverse comple-
ment of oligonucleotides (5′-AAGGGTAGAACGAT
CATTC-TCCCTCG-3′). The annealing reaction was
performed as explained above. The DOS was further di-
luted to 2 μM. The GST-Bxe_B3018 protein was diluted
to a stock solution of 17 μM in buffer B containing 25%
glycerol. The reaction mixtures consisted of 1.0 μM of
DOS and protein concentrations of 10 μM in 20 mM
Tris-Cl, 500 μM EDTA, 5% glycerol, 200 μM DTT,
0.001% Triton X, 50 mM NaCl, 5 mM MgCl2, 2.5 mM
CaCl2 at pH 8.0 (buffer E). The aminoacetone,
aminopropan-2-ol and methylglyoxal concentrations
ranged from 10 to 20 mM. The reaction mixtures were
incubated at room temperature for 30 min. A 5% native
polyacrylamide gel was pre-run for 20 min at 8 V/cm in
TBE buffer composed of 44 mM Tris, 44 mM Borate,
1.0 mM EDTA at pH 8.3. Then, the samples were
loaded and run at 8 V/cm until the bromophenol yel-
low (loading dye) migrated 1/3 down the gel. Gels were
stained with ethidium bromide, imaged on a BIORAD
ChemiDoc XRS imaging station.In-vivo validation of effectors by real-time PCR
B. xenovorans cells were grown in tripticase soy broth
until they reached 0.6 OD600nm. One mL aliquots were
treated with 1 mM aminoacetone, aminopropan-2-ol or
methylglyoxal and incubated for 30 min under constant
shaking. B. xenovorans cell were collected by centrifu-
gation at 6,000 × g and RNA was isolated from the
treated cells using the Qiagen RNeasy-mini-kit (Qia-
gen) followed by removal of DNA using a Turbo DNA-
free kit (Life Technologies) according to manufacturer’s
instructions. The RNA was then analyzed for purity
and concentration on a Nano Drop 1000 spectropho-
tometer. 100 ng of RNA was converted to cDNA in a
20 μL reaction using High Capacity RNA-to-cDNA
(Life Technologies) following the manufacturer’s proto-
col. Real-Time PCR assays were run in triplicate using
2 μL of a 1:10 dilution of cDNA per reaction. MGB
TaqMan® assays for Bxe_B3016, Bxe_B3017, Bxe_B3018
and 16 s were designed and ordered from Life Technologies
Custom TaqMan Gene Expression assay design tool
(https://www.lifetechnologies.com/order/custom-genomic-
products/tools/gene-expression/). Reactions were carried
out using TaqMan® Fast Universal PCR Master Mix (2×),
No AmpErase UNG (ABI #4352042) on ABI 7500 DX
instruments run in fast mode with the following cycling
parameters: 1 cycle 95°C for 20 s followed by 40 cycles
95°C for 3 s and 60°C for 30 s. Data were analyzed using
the Data Assist v3.01 Real-Time PCR analysis software
(Life Technologies). The relative gene expression values
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change of the ΔΔCT was compared across all data sets.Ethics
There were no vertebrate or invertebrate subjects used
in this investigation.Additional files
Additional file 1: Code. Zip folder containing all files required to run
the Java™ application. The files need to be extracted to the same folder
and then the FunctionDiscoveryV1.0.jar interface can be launched. For
detailed instructions on how to use the interface please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 2: Result BetI. Function Discovery V1.0 output (.html
format) for the glycine betaine biosynthesis regulator (BetI, Bxe_B1590).
For detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 3: Result CatR. Function Discovery V1.0 output (.html
format) for the benzoate degradation regulator (CatR, Bxe_ A2107). For
detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 4: Result CymR. Function Discovery V1.0 output (.html
format) for the p-cumate catabolism regulator (CymR, Bxe_ A3550). For
detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 5: Result CysB. Function Discovery V1.0 output (.html
format) for the sulfur metabolism regulator (CysB, Bxe_ A2466). For
detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 6: Result GlpR. Function Discovery V1.0 output (.html
format) for the glycerol metabolism regulator (GlpR, Bxe_ A0643). For
detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 7: Result HpaR. Function Discovery V1.0 output (.html
format) for the hydroxyphenylacetate catabolism regulator (HpaR, Bxe_
B2027). For detailed instructions on how to analyze the results please
refer to the Function Discovery V1.0, a gene neighborhood analysis tool
section in the Results part of the main text.
Additional file 8: Result KynR. Function Discovery V1.0 output (.html
format) for the oxidative tryptophan degradation regulator (KynR, Bxe_
A0736). For detailed instructions on how to analyze the results please
refer to the Function Discovery V1.0, a gene neighborhood analysis tool
section in the Results part of the main text.
Additional file 9: Result HutC. Function Discovery V1.0 output (.html
format) for the histidine degradation regulator (HutC, Bxe_ A2946). For
detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 10: Result RcoM. Function Discovery V1.0 output (.html
format) for the carbon monoxide oxidation regulator (RcoM, Bxe_ A2142).
For detailed instructions on how to analyze the results please refer to the
Function Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 11: Result ModE. Function Discovery V1.0 output (.html
format) for the molybdate transport regulator (ModE, Bxe_ B2851). For
detailed instructions on how to analyze the results please refer to theFunction Discovery V1.0, a gene neighborhood analysis tool section in
the Results part of the main text.
Additional file 12: Figure Af1. Dendrogram of microbial Bxe_B3018
Homologues. BLAST analysis (utilizing a 40 aa-IDc) identified the existence
of 81 homologs. These homologs were found only in Burkholderia or
Pseudomonas genomes.
Additional file 13: Result Bxe_B3018. Function Discovery V1.0 output
(.html format) for the previously unknown function transcriptional
regulator (Bxe_ B3018, MgxR). For detailed instructions on how to analyze
the results please refer to the Function Discovery V1.0, a gene
neighborhood analysis tool section in the Results part of the main text.
Additional file 14: Figure Af2. Structures for the library of candidate
effector metabolites predicted from the analysis of the Function
Discovery V1.0 output for Bxe_B3018.
Additional file 15: Figure Af3. Flowchart describing the steps used by
the Function Discovery V1.0 software to predict the metabolic
involvement of a given TR.
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